These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 11575979)

  • 1. The benefit of implementing a heart failure disease management program.
    Whellan DJ; Gaulden L; Gattis WA; Granger B; Russell SD; Blazing MA; Cuffe MS; O'Connor CM
    Arch Intern Med; 2001 Oct; 161(18):2223-8. PubMed ID: 11575979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacotherapy Treatment Patterns, Outcomes, and Health Resource Utilization Among Patients with Heart Failure with Reduced Ejection Fraction at a U.S. Academic Medical Center.
    Bress AP; King JB; Brixner D; Kielhorn A; Patel HK; Maya J; Lee VC; Biskupiak J; Munger M
    Pharmacotherapy; 2016 Feb; 36(2):174-86. PubMed ID: 26841333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prescribing patterns of evidence-based heart failure pharmacotherapy and outcomes in the ASIAN-HF registry: a cohort study.
    Teng TK; Tromp J; Tay WT; Anand I; Ouwerkerk W; Chopra V; Wander GS; Yap JJ; MacDonald MR; Xu CF; Chia YM; Shimizu W; ; Richards AM; Voors A; Lam CS
    Lancet Glob Health; 2018 Sep; 6(9):e1008-e1018. PubMed ID: 30103979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost effectiveness of carvedilol for heart failure.
    Delea TE; Vera-Llonch M; Richner RE; Fowler MB; Oster G
    Am J Cardiol; 1999 Mar; 83(6):890-6. PubMed ID: 10190405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case management in a heterogeneous congestive heart failure population: a randomized controlled trial.
    Laramee AS; Levinsky SK; Sargent J; Ross R; Callas P
    Arch Intern Med; 2003 Apr; 163(7):809-17. PubMed ID: 12695272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of chronic heart failure in a managed care setting. Baseline results from the Achieving Cardiac Excellence Project.
    Schmedtje JF; Evans GW; Byerly W; King M; Goonan K; Blastock-Glenn C; Croft JB; Goff DC
    N C Med J; 2003; 64(1):4-10. PubMed ID: 12774552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug copayment and adherence in chronic heart failure: effect on cost and outcomes.
    Cole JA; Norman H; Weatherby LB; Walker AM
    Pharmacotherapy; 2006 Aug; 26(8):1157-64. PubMed ID: 16863491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The economic burden of congestive heart failure in a managed care population.
    Xuan J; Duong PT; Russo PA; Lacey MJ; Wong B
    Am J Manag Care; 2000 Jun; 6(6):693-700. PubMed ID: 10977478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of heart failure program on cardiovascular drug utilization and dosage in patients with chronic heart failure.
    Ramahi TM; Longo MD; Rohlfs K; Sheynberg N
    Clin Cardiol; 2000 Dec; 23(12):909-14. PubMed ID: 11129677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost/utility ratio in chronic heart failure: comparison between heart failure management program delivered by day-hospital and usual care.
    Capomolla S; Febo O; Ceresa M; Caporotondi A; Guazzotti G; La Rovere M; Ferrari M; Lenta F; Baldin S; Vaccarini C; Gnemmi M; Pinna G; Maestri R; Abelli P; Verdirosi S; Cobelli F
    J Am Coll Cardiol; 2002 Oct; 40(7):1259-66. PubMed ID: 12383573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of the short form 36 in a primary care based disease management program for patients with congestive heart failure.
    Sidorov J; Shull RD; Girolami S; Mensch D
    Dis Manag; 2003; 6(2):111-7. PubMed ID: 14577905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic implications of treatment guidelines for congestive heart failure.
    Shibata MC; Nilsson C; Hervas-Malo M; Jacobs P; Tsuyuki RT
    Can J Cardiol; 2005 Dec; 21(14):1301-6. PubMed ID: 16341301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pharmacoeconomic assessment of torsemide and furosemide in the treatment of patients with congestive heart failure.
    Noe LL; Vreeland MG; Pezzella SM; Trotter JP
    Clin Ther; 1999 May; 21(5):854-66. PubMed ID: 10397380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prescribing trends for management of congestive heart failure from 2002 to 2004.
    Crawford T; Segars LW; Rasu RS
    Res Social Adm Pharm; 2013; 9(4):482-9. PubMed ID: 21272523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of medication supply on hospitalizations and health-care costs in patients with chronic heart failure.
    Dilokthornsakul P; Chaiyakunapruk N; Nimpitakpong P; Jeanpeerapong N; Sruamsiri R
    Value Health; 2012; 15(1 Suppl):S9-14. PubMed ID: 22265074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of home patient telemonitoring on use of β-blockers in congestive heart failure.
    Antonicelli R; Mazzanti I; Abbatecola AM; Parati G
    Drugs Aging; 2010 Oct; 27(10):801-5. PubMed ID: 20883060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-blockers and angiotensin-converting enzyme inhibitors/receptor blockers prescriptions after hospital discharge for heart failure are associated with decreased mortality in Alberta, Canada.
    Johnson D; Jin Y; Quan H; Cujec B
    J Am Coll Cardiol; 2003 Oct; 42(8):1438-45. PubMed ID: 14563589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic pacemaker use to allow beta-blocker therapy in patients with chronic heart failure with bradycardia.
    Stecker EC; Fendrick AM; Knight BP; Aaronson KD
    Am Heart J; 2006 Apr; 151(4):820-8. PubMed ID: 16569541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multinational economic evaluation of valsartan in patients with chronic heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT).
    Reed SD; Friedman JY; Velazquez EJ; Gnanasakthy A; Califf RM; Schulman KA
    Am Heart J; 2004 Jul; 148(1):122-8. PubMed ID: 15215801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Outpatient medical and nurse management program in patients with chronic heart failure in a large territorial area in Piedmont. Four years of follow-up].
    Conte MR; Mainardi L; Iazzolino E; Casetta M; Asteggiano R; Lai F; Lusardi R; Sasso L
    Ital Heart J Suppl; 2005 Dec; 6(12):812-20. PubMed ID: 16444925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.